Publication | Closed Access

IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment

Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyImmunoeditingCancer GrowthImmune Checkpoint InhibitorMetastatic LesionsImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentTumor BiologyDistinct Compartments